A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)

Inclusion Criteria: * Subject is male 18 to 45 years of age at screening * Subject has a stable weight (± 2 kg) for more then 6 weeks prior to screening Exclusion Criteria: * Subject has a history of ileal bypass, gastric bypass, or other significant condition associated with malabsorption * Subject has an active or recent (\<2 weeks) gastrointestinal condition (gastroenteritis, diarrhea, chronic constipation, irritable bowl syndrome, etc.) affecting bowel movements * Subject has a known allergy to beans, peas, eggs or egg-derived products and/or soy or soy-derived products * Subject has a history of plant sterol storage disease (sitosterolemia, cerebrotendinotic xanthomatosis) or a history of intolerance to plant sterols and/or plant sterol containing products * Subject has a history of hepatic or gall bladder disease (including gallstones, cholecystectomy, etc.) * Subject is currently taking psyllium, other fiber-based laxatives, phytosterol margarines, and/or over the counter (OTC) therapies that are known to affect serum lipids * Subject has taken lipid-lowering agents within 6 weeks prior to screening * Subject has previously been administered an intravenous infusion of \[13C3,4\]-cholesterol